Significance of hemoglobin and hematocrit changes in predicting patient survival and efficacy of neoadjuvant chemotherapy for advanced gastric cancer
Hematocrit < 33% and hemoglobin < 107 g/L are risk factors for chemotherapy failure in patients with advanced gastric cancer. They are associated with poorer prognosis and reduced 3-year survival rates.
Authors
- Hong Wen (ORCID: https://orcid.org/0000-0002-1411-5939)
- Yi‐Long Huang (ORCID: https://orcid.org/0000-0002-0980-4828)
- Tian Qiu (ORCID: https://orcid.org/0009-0001-0286-6188)
Institutions
- Third People's Hospital of Chengdu (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-06-13
- DOI
- https://doi.org/10.4251/wjgo.v17.i6.104592
- Citations
- 2
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09